XML 28 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2018   10,862,651    
Beginning balance at Dec. 31, 2018 $ 191,542 $ 62,855 $ 132,460 $ (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,156   6,156  
Net unrealized gain on securities available for sale, net of tax 3,512     3,512
Net unrealized loss on cash flow hedging derivative instruments, net of tax (465)     (465)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 3     3
Comprehensive income (loss) 9,206   6,156 3,050
Cash dividends declared (3,156)   (3,156)  
Equity compensation expense 123 $ 123    
Payment to repurchase common stock (in shares)   (3,804)    
Payment to repurchase common stock (96)   (96)  
Issuance of restricted stock (in shares)   19,087    
Proceeds from sale of common stock (in shares)   6,447    
Proceeds from sale of common stock $ 168 $ 168    
Ending balance (in shares) at Mar. 31, 2019 10,884,381 10,884,381    
Ending balance at Mar. 31, 2019 $ 197,787 $ 63,146 135,364 (723)
Beginning balance (in shares) at Dec. 31, 2019 10,899,210 10,899,210    
Beginning balance at Dec. 31, 2019 $ 212,508 $ 64,073 144,839 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,495   6,495  
Net unrealized gain on securities available for sale, net of tax 4,233     4,233
Net unrealized loss on cash flow hedging derivative instruments, net of tax (4,870)     (4,870)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 8     8
Comprehensive income (loss) 5,866   6,495 (629)
Cash dividends declared (3,276)   (3,276)  
Equity compensation expense 150 $ 150    
Payment to repurchase common stock (in shares)   (5,297)    
Payment to repurchase common stock (154)   (154)  
Issuance of restricted stock (in shares)   21,595    
Proceeds from sale of common stock (in shares)   5,698    
Proceeds from sale of common stock $ 163 $ 163    
Ending balance (in shares) at Mar. 31, 2020 10,921,206 10,921,206    
Ending balance at Mar. 31, 2020 $ 215,257 $ 64,386 $ 147,904 $ 2,967